While, not acting directly in concert, the phagocytic stimulation provided by RT-induced calreticulin can be enhanced by blocking the anti-phagocytic signal CD47 which leads to increased dendritic cell and macrophage activation and improved anti-tumor immunity (51, 52). The gene discussed is CALR; the disease is neoplasm.